Form 4: Alphatec Director David Demski Receives Stock Grant

Director David M. Demski was granted 32,012 restricted stock units by Alphatec Holdings, Inc. on June 10, 2026.

Summary

• Director David M. Demski received a grant of 32,012 restricted stock units (RSUs) from Alphatec Holdings, Inc.
• Each RSU represents a contingent right to receive one share of common stock.
• The total beneficial ownership for the director following this transaction is 431,635 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on the company's financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• The grant results in minor shareholder dilution.

Risks

• Vesting is subject to the director's continued service until the next annual meeting.

Future Outlook

The RSUs vest on the earlier of the next annual meeting of stockholders or the death/resignation of the reporting person.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices intended to incentivize long-term performance and align leadership with shareholder value.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is consistent with standard compensation practices for mid-cap medical device companies.
• Vesting schedules tied to annual meetings are common practice in the healthcare sector.

Corporate Governance

Stakeholder Impact

• Minor dilution for existing shareholders due to the issuance of new equity.

Next Steps

• Vesting of the 32,012 RSUs at the next annual meeting of stockholders.

Key Dates

Keywords

Alphatec Holdings, ATEC, Form 4, Insider Transaction, Restricted Stock Units, Director Compensation